Anavex Life Sciences Corp.
| OTC Markets: AVXL
Anavex Life Sciences Corp. is a biopharmaceutical company engaged in the discovery and development of new drugs for the treatment of neurological diseases and cancer, utilizing its proprietary drug discovery sigmaceptor platform. The company's portfolio comprises novel, wholly owned sigma receptor agonists and antagonists. Anavex Life Sciences was founded by Harvey Lalach on January 23, 2004 and is headquartered in New York, NY.